Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

This study has been withdrawn prior to enrollment.
(New sponsor's existing product under evaluation for this indication)
Sponsor:
Information provided by:
Biotest Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT00800787
First received: November 26, 2008
Last updated: June 29, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)